{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026#webpage",
"url": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026",
"name": "Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2026",
"description": "Explore this Fortrea Info Sheet featuring a collection of peer-reviewed oncology publications authored and co-authored by Fortrea oncologists between 2020 and 2026. The publication portfolio highlights scientific research and clinical insights across a broad spectrum of oncology topics, including precision oncology, immuno-oncology, biomarker-driven research, genomic profiling, antibody-drug conjugates, targeted therapies, and personalized cancer treatment. These publications contribute to the understanding of emerging therapeutic approaches, advances in oncology drug development, and innovations in clinical research designed to improve patient outcomes. Spanning multiple tumor types and areas of cancer research, the collection demonstrates Fortrea's ongoing commitment to scientific excellence, evidence generation, and the advancement of oncology through peer-reviewed research, clinical expertise, and collaboration across the global cancer research community."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Peer-reviewed journal articles featuring Fortrea oncologists published 2020-2026",
"item": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026#infosheet",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/peer-reviewed-journal-articles-featuring-fortrea-oncologists-published-2020-2026#webpage"
},
"headline": "Peer-Reviewed Oncology Research Supporting Innovation in Cancer Treatment 2020-2026 | Fortrea Info Sheet",
"description": "Explore this Fortrea Info Sheet featuring a collection of peer-reviewed oncology publications authored and co-authored by Fortrea oncologists between 2020 and 2026. The publication portfolio highlights scientific research and clinical insights across a broad spectrum of oncology topics, including precision oncology, immuno-oncology, biomarker-driven research, genomic profiling, antibody-drug conjugates, targeted therapies, and personalized cancer treatment. These publications contribute to the understanding of emerging therapeutic approaches, advances in oncology drug development, and innovations in clinical research designed to improve patient outcomes. Spanning multiple tumor types and areas of cancer research, the collection demonstrates Fortrea's ongoing commitment to scientific excellence, evidence generation, and the advancement of oncology through peer-reviewed research, clinical expertise, and collaboration across the global cancer research community.",
"genre": "Info Sheet",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-03/fortrea-oncologists-published-2020-2025.jpg"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-03-17",
"dateModified": "2025-03-17",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2026-04/fortrea-oncology-articles-2020-2026.pdf",
"encodingFormat": "application/pdf"
}
}
]
}